How much does Alunbrig (Brigatinib Tablets) Cost& price without insurance in China?
Alunbrig® is the commercial brand name of Brigatinib Tablets, an orally active dual ALK/EGFR tyrosine kinase inhibitor developed by Takeda Pharmaceutical. It blocks abnormal ALK-driven downstream signaling cascade to suppress proliferation of ALK-rearranged tumor cells.
Main Indications
Treatment for adult patients with anaplastic lymphoma kinase-positive locally advanced or metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
Common Side Effects
Common mild adverse reactions: Fatigue, diarrhea, nausea, cough and elevated blood creatine phosphokinase.
Laboratory abnormalities: Transient hepatic transaminase increase and hyperlipidemia.
Severe but manageable risks: Interstitial lung disease/pneumonitis, severe hypertension and visual impairment.
Approval Status in China
Alunbrig® (Brigatinib Tablets, 90mg) was officially approved for marketing in China in 2021. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Alunbrig (Brigatinib Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
